摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (E)-3-(4-octylphenyl)acrylate | 1227-60-7

中文名称
——
中文别名
——
英文名称
methyl (E)-3-(4-octylphenyl)acrylate
英文别名
4-Octyl-trans-zimtsaeure-methylester;methyl (E)-3-(4-octylphenyl)prop-2-enoate
methyl (E)-3-(4-octylphenyl)acrylate化学式
CAS
1227-60-7
化学式
C18H26O2
mdl
——
分子量
274.403
InChiKey
DZZBTHQTUWBIOR-CCEZHUSRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.2
  • 重原子数:
    20
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl (E)-3-(4-octylphenyl)acrylate 在 palladium 10% on activated carbon 、 氢气 作用下, 以 甲醇 为溶剂, 反应 12.0h, 生成 methyl 3-(4-octylphenyl)propanoate
    参考文献:
    名称:
    Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model
    摘要:
    Autotaxin (ATX) catalyzes the hydrolysis of lysophosphatidylcholine (LPC) generating the lipid mediator lysophosphatidic acid (LPA). Both ATX and LPA are involved in various pathological inflammatory conditions, including fibrosis and cancer, and have attracted great interest as medicinal targets over the past decade. Thus, the development of novel potent ATX inhibitors is of great importance. We have developed a novel class of ATX inhibitors containing the zinc binding functionality of hydroxamic acid. Such novel hydroxamic acids that incorporate a non-natural delta-amino acid residue exhibit high in vitro inhibitory potency over ATX (IC50 values 50-60 nM). Inhibitor 32, based on delta-norleucine, was tested for its efficacy in a mouse model of pulmonary inflammation and fibrosis induced by bleomycin and exhibited promising efficacy. The novel hydroxamic ATX inhibitors provide excellent tools for the study of the role of the enzyme and could contribute to the development of novel therapeutic agents for the treatment of fibrosis and other chronic inflammatory diseases.
    DOI:
    10.1021/acs.jmedchem.8b00232
  • 作为产物:
    描述:
    4-辛基苯甲醛哌啶 作用下, 以 吡啶 为溶剂, 生成 methyl (E)-3-(4-octylphenyl)acrylate
    参考文献:
    名称:
    Tsatsas,G. et al., Bulletin de la Societe Chimique de France, 1964, p. 2615 - 2617
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] PHENOLIC COMPOUND, SKIN-WHITENING COSMETIC COMPOSITION COMPRISING SAME, AND SKIN-WHITENING COSMETIC PRODUCT<br/>[FR] COMPOSÉ PHÉNOLIQUE, COMPOSITION COSMÉTIQUE DE BLANCHIMENT DE LA PEAU LE COMPRENANT, ET PRODUIT COSMÉTIQUE DE BLANCHIMENT DE LA PEAU<br/>[KO] 페놀계 화합물, 이를 포함하는 피부미백용 화장품 조성물 및 피부미백 화장품
    申请人:CELLINBIO CO LTD
    公开号:WO2021125418A1
    公开(公告)日:2021-06-24
    본 발명은 하기 화학식 1의 구조를 가지는 페놀계 화합물 및 이의 화장품공학적으로 허용되는 염을 유효성분으로 함유하는 피부미백용 화장품 조성물과, 상기 조성물을 포함하는 피부미백용 화장품에 관한 것이다. 본 발명의 페놀계 화합물은 피부 미백 활성이 우수할 뿐만 아니라, 세포 독성이 없으며, 활성산소를 억제하여, 인체에 무해하여 안전성이 뛰어나다. [화학식 1]
  • Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit <i>in Vivo</i> Efficacy in a Pulmonary Fibrosis Model
    作者:Aikaterini Nikolaou、Ioanna Ninou、Maroula G. Kokotou、Eleanna Kaffe、Antreas Afantitis、Vassilis Aidinis、George Kokotos
    DOI:10.1021/acs.jmedchem.8b00232
    日期:2018.4.26
    Autotaxin (ATX) catalyzes the hydrolysis of lysophosphatidylcholine (LPC) generating the lipid mediator lysophosphatidic acid (LPA). Both ATX and LPA are involved in various pathological inflammatory conditions, including fibrosis and cancer, and have attracted great interest as medicinal targets over the past decade. Thus, the development of novel potent ATX inhibitors is of great importance. We have developed a novel class of ATX inhibitors containing the zinc binding functionality of hydroxamic acid. Such novel hydroxamic acids that incorporate a non-natural delta-amino acid residue exhibit high in vitro inhibitory potency over ATX (IC50 values 50-60 nM). Inhibitor 32, based on delta-norleucine, was tested for its efficacy in a mouse model of pulmonary inflammation and fibrosis induced by bleomycin and exhibited promising efficacy. The novel hydroxamic ATX inhibitors provide excellent tools for the study of the role of the enzyme and could contribute to the development of novel therapeutic agents for the treatment of fibrosis and other chronic inflammatory diseases.
  • Tsatsas,G. et al., Bulletin de la Societe Chimique de France, 1964, p. 2615 - 2617
    作者:Tsatsas,G. et al.
    DOI:——
    日期:——
查看更多